retatrutide phase 2 results obesity nejm 2023 in adults with over 104 weeks in the highest dose group had 30.3% weight loss. Nearly 2/3 reached BMI < 30 1 in 3 reached BMI < 25 Retatrutide vs Semaglutide: Triple vs

Gradual Dose Increase Rapid dose escalation may increase gastrointestinal side effects

The sustained reduction suggests ongoing hepatic benefits throughout treatment

Free fatty acids are released into the bloodstream, but unless you are in a caloric deficit or exercising to oxidize those fatty acids, they are simply re-esterified and stored again

D-Ala2GIP facilitated synaptic plasticity and reduces plaque load in aged wild type mice and in an Alzheimers disease mouse model

The 5 mg formulation typically represents an intermediate titration dose used to evaluate patient response and minimize gastrointestinal side effects during dose escalation in clinical studies

Maybe a slight queasiness after meals